Table 3.
Secondary effect | Schedule | N or % | |
---|---|---|---|
David36 | Depression+ | 100 mg/day 20 days and 10 days drug free | 19%–47% |
Boukozoba42 | Breast tenderness | 100 mg/day 20 days and 10 days drug free for 3 months | 1.2% |
Insomnia | 0.6% | ||
Mouth dryness | 0.6% | ||
Somnolence | 1.2% | ||
Digestive problems | 0.6% | ||
Dizziness | 0.6% | ||
Weakness | 0.6% | ||
Masmoudi46 | Parkinsonism | Several schedules | N |
Acute dyskinesia | 15 | ||
Parkinsonism plus other in 8 cases | 2 | ||
Tardive dyskinesia | 6 | ||
Postural tremor | 3 | ||
Myoclonia | 1 | ||
Dystonia | 1 | ||
Montemurro47 | Acute coronary syndrome | 100 mg/day | 1 |
Kunhardt48 | Pyrosis | 100 mg/day 20 days | 1 |
Hair fall | and 10 days drug free | 1 | |
Mamary pruritus | 1 | ||
Mastodynia | 3 | ||
Placebo | |||
Headache, joint pain, vaginal discharge mastodynia 1/e | 1 each | ||
Raja49 | Tardive dyskinesia | Not reported | 1 |
Sining50 | Dystonia (Hypertension under enalapril treatment) | 100 mg/day (2 months) | 1 |
Teive51 | Increase in | Not reported | 1 |
Parkinsonian symptoms |